Cargando…
Liposomal daunorubicin as treatment for Kaposi’s sarcoma
Anthracycline compounds including daunorubicin are the foundation of many modern chemotherapeutic regimens. However, the side-effects of these compounds can be severe, leading to alopecia, nausea, immune deficiency, and cardiotoxicity. For immunocompromised patients with aggressive Kaposi’s sarcoma...
Autores principales: | Petre, Christin E, Dittmer, Dirk P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676651/ https://www.ncbi.nlm.nih.gov/pubmed/18019828 |
Ejemplares similares
-
Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma
por: Udhrain, Ashish, et al.
Publicado: (2007) -
Treatment of Kaposi Sarcoma-Associated Herpesvirus-Associated Cancers
por: Dittmer, Dirk P., et al.
Publicado: (2012) -
Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma
por: Cainelli, Francesca, et al.
Publicado: (2009) -
Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin
por: Coldiron, Matthew E., et al.
Publicado: (2021) -
Imaging of Kaposi sarcoma
por: Addula, Dhivya, et al.
Publicado: (2021)